MED32/442: Internet Lectures: A five years experience at the University of Vienna

por Kritz, H, Najemnik, C, Sinzinger, H
Publicado 1999

Decrease of prostaglandin I2 binding sites in thyroid cancer.

por Virgolini, I., Hermann, M., Sinzinger, H.
Publicado 1988

Human hepatocellular cancers show decreased prostaglandin E1 binding capacity.

por Virgolini, I., Sinzinger, H., Müller, C., Hermann, M.
Publicado 1989

Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.

por Virgolini, I., Müller, C., Klepetko, W., Angelberger, P., Bergmann, H., O'Grady, J., Sinzinger, H.
Publicado 1990

Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.

por Virgolini, I., Kornek, G., Höbart, J., Li, S. R., Raolerer, M., Bergmann, H., Scheithauer, W., Pantev, T., Angelberger, P., Sinzinger, H.
Publicado 1993